APTENSIO XR 50 MG CAPSULE

methylphenidate hydrochloride
$7.9978per EA
DEA Schedule CII

Strength

50 mg/1

NDC

42858040645

Classification

Brand

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Last Updated

7/23/2025

Approval Type

New Drug (NDA)

FDA Application

NDA205831

On Market Since

4/17/2015

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

+0.4%

3Y

-0.6%

5Y

-0.6%

All

+16.5%